Enovis

Yahoo Finance • 2 days ago

Enovis completes sale of its Dr. Comfort Footcare Solutions business for proceeds of up to $60 million

Wilmington, DE, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, today announced the sale of its Dr. Comfort diabetic shoe business t... Full story

Yahoo Finance • last month

Enovis Corporation Announces Time Change for Presentation at Baird 2025 Global Healthcare Conference

Wilmington, DE, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will now present at the Baird 2025 Global Healthcare Conference at 2:3... Full story

Yahoo Finance • 2 months ago

Tandem Diabetes, Enovis, Dentsply Sirona, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer Price Index (CPI) report,... Full story

Yahoo Finance • 2 months ago

UBS Lowers PT on Enovis Corporation (ENOV) to $57 From $65, Keeps a Buy Rating

Enovis Corporation (NYSE:ENOV) is one of the best medical device stocks to buy according to analysts. On August 8, UBS lowered the firm’s price target on Enovis Corporation (NYSE:ENOV) to $57 from $65, keeping a Buy rating on the shares.... Full story

Yahoo Finance • 2 months ago

Moderna, Teleflex, Envista, Enovis, and UnitedHealth Shares Are Soaring, What You Need To Know

What Happened? A number of stocks jumped in the morning session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed inflation rose by a modest 0.2... Full story

Yahoo Finance • 2 months ago

ENOV December 2026 Options Begin Trading

Investors in Enovis Corp (Symbol: ENOV) saw new options become available today, for the December 2026 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 494 days u... Full story

Yahoo Finance • 2 months ago

Enovis to Participate in Upcoming Investor Conferences

Wilmington, DE, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences... Full story

Yahoo Finance • 2 months ago

Enovis raises 2025 revenue guidance to $2.275B amid CEO transition and product momentum

Earnings Call Insights: Enovis Corporation (ENOV) Q2 2025 MANAGEMENT VIEW * Damien McDonald, in his first earnings call as CEO, emphasized his commitment to shareholders and outlined a multiyear roadmap focused on "profitable, capital-... Full story

Yahoo Finance • 2 months ago

Enovis Corp (NYSE:ENOV) Reports Mixed Q2 2025 Results with EPS Beat and Revenue Miss

Enovis Corp (NYSE:ENOV [https://www.chartmill.com/stock/quote/ENOV/profile]) reported its second-quarter 2025 financial results, delivering mixed performance relative to analyst expectations. The medical technology company posted revenue o... Full story

Yahoo Finance • 2 months ago

Enovis Q2 2025 slides: Revenue and EPS growth accelerate, guidance raised

Introduction & Market Context Enovis Corporation (NYSE:ENOV) released its second quarter 2025 results on August 7, showing accelerated growth and improved profitability that prompted management to raise full-year guidance. The medical tec... Full story

Yahoo Finance • 2 months ago

Enovis Announces Second Quarter 2025 Results

Continued commercial momentum with second-quarter sales growth of 7% on a reported basis Second-quarter Reconstructive sales grew 11% year-over-year on a reported basis Wilmington, DE, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporat... Full story

Yahoo Finance • 2 months ago

Enovis Corporation Q2 2025 Earnings Preview

* Enovis Corporation (NYSE:ENOV [https://seekingalpha.com/symbol/ENOV]) is scheduled to announce Q2 earnings results on Thursday, August 7th, before market open. * The consensus EPS Estimate is $0.72 [https://seekingalpha.com/symbol/EN... Full story

Yahoo Finance • 3 months ago

Enovis (ENOV) Stock Trades Up, Here Is Why

What Happened? Shares of medical technology company Enovis Corporation (NYSE:ENOV) jumped 3.3% in the morning session after the stock gained ground amid a broader market rally as investors looked ahead to a busy week of corporate earnings... Full story

Yahoo Finance • 3 months ago

Enovis stock hits 52-week low at 28.81 USD

Enovis Corp’s stock reached a new 52-week low, closing at 28.81 USD. According to InvestingPro analysis, the medical technology company, currently valued at $1.65 billion, appears undervalued based on its Fair Value metrics. This marks a s... Full story

Yahoo Finance • 3 months ago

Guardant Health, Gilead Sciences, Inspire Medical Systems, Enovis, and AMN Healthcare Services Stocks Trade Down, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market sentiment turned negative after the White... Full story

Yahoo Finance • 3 months ago

Enovis to Host Second Quarter 2025 Results Conference Call on August 7th

Wilmington, DE, July 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its second q... Full story

Yahoo Finance • 4 months ago

Enovis stock hits 52-week low at 29.11 USD

Enovis stock reached a 52-week low, hitting a price of 29.11 USD, significantly below its 52-week high of 49.83 USD. Over the past year, the company’s stock has experienced a significant decline, with a 1-year change showing a decrease of... Full story

Yahoo Finance • 6 months ago

Enovis to Host First Quarter 2025 Results Conference Call on May 8th

Wilimington, DE, April 17, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its first... Full story

Yahoo Finance • 6 months ago

Medical Devices & Supplies - Specialty Stocks Q4 Teardown: Integer Holdings (NYSE:ITGR) Vs The Rest

Medical Devices & Supplies - Specialty Stocks Q4 Teardown: Integer Holdings (NYSE:ITGR) Vs The Rest Let’s dig into the relative performance of Integer Holdings (NYSE:ITGR) and its peers as we unravel the now-completed Q4 medical devices &... Full story

Yahoo Finance • 6 months ago

Enovis Announces Appointment of Damien McDonald as Chief Executive Officer

Damien McDonald appointed CEO, effective as of May 12, 2025Company reiterates guidance for first quarter revenues and aEBITDA WIlmington. DE, April 02, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “The Company”) (NYSE: ENO... Full story